Lark Health, the leader in chronic disease prevention and management using A.I. counseling, announces the appointment of Dr. Sharon Rapoport as its Vice President of Data Science.
MyWay Digital Health has successfully secured one of seven NHS Test Beds to MyDiabetesMyWay platform to Greater Manchester. Patients with type 2 diabetes in the greater Manchester area will be able to access their medical records through our MyDiabetesMyWay website and mobile app to help with the management of their diabetes.
#mobile app
This is a cluster randomized controlled trial in eight primary health centers. Participants were physically inactive, aged ≥18 years, and with no contraindication to PA. Patients attending intervention health centers (n=4) received the ‘MOVEdiabetes’ intervention, which consisted of personalized, individual face-to-face consultations by dietitians. Pedometers and monthly telephone WhatsApp messages were also used. Patients attending comparison health centers received usual care.
Connecting the dots in diabetes management by creating an open ecosystem will support a faster response to the therapy challenges of people with diabetes, caregivers and healthcare systems and contribute to sustainable provision of care. “We have successfully embarked on the journey to co-create a leading open diabetes management ecosystem with all stakeholders involved in the care process as well as partners”, states Marcel Gmuender, Global Head of Roche Diabetes Care.
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced that Novo Nordisk’s Fiasp® (Fast-Acting Insulin Aspart) has been tested and found safe for use in Insulet’s Omnipod System in Europe.
#insulin pump
Fit4D, a leading diabetes management technology-enabled services company based in New York City, announces the appointment of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s board.
The exercise period for Brighter's management, board and key personnel incentive programs 2014/2017 Series I & II and 2015/2018 Series I & II is now completed. The company has received a total of SEK 29,369,024 through the programs.
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced that it has received a Heath Canada Medical Device License for the t:slim X2™ Insulin Pump.
#insulin pump
Demonstrating a continued commitment to making diabetes management and support tools available to everyone, One Drop today announced the addition of Brian Kemper as Vice President of Integrated Care.
Teladoc Health (NYSE: TDOC), the global leader in virtual care, is pleased to announce, effective today, the appointment of Mark Douglas Smith, MD, MBA, to its board of directors. Dr. Smith is a professor of clinical medicine at the University of California at San Francisco (UCSF) and a nationally-recognized health policy and delivery system expert.